webinar register page

Webinar banner
First void urine & HPV genotyping - Two essential tools to monitor the impact of HPV vaccination programs.
The enormous potential of a first void – or initial stream – urine sample becomes evident when we understand it’s composition. In fact, in the case of women a first void urine sample could also be called “A genital sample collected by urination”. Prof Alex Vorsters will present his understanding in this field leading to the development of the Colli-Pee® urine collection device. Data will be presented, confirming that improved collection of a first void urine sample as well as its immediate preservation have a major impact on HPV DNA detection. Further to that, the results from a large HPV vaccination follow-up study will be discussed. For monitoring HPV vaccination trials, the use of a sensitive and full individual genotyping assay such as the INNO-LiPA HPV Genotyping Extra II, provides important information on the impact of the vaccination program.

Topics covered:

• Data confirming that improved collection of a first void urine sample as well as its immediate preservation have a major impact on HPV DNA detection

• Results from large HPV vaccination follow-up study

• Important information on the impact of the vaccination program, provided by the use of a sensitive and full individual genotyping assay such as the INNO-LiPA HPV genotyping Extra II.

After the presentation, a panel with Prof Alex Vorsters, accompanied by David Faster of Novosanis and Rebecca Millecamps of Fujirebio, will answer your questions.

Bring your questions to the live event or submit them in the registration form below to ensure they will be properly addressed.

*By submitting my request, I consent to receive follow-up email from Novosanis. You may opt-out at anytime.

Nov 19, 2020 11:00 AM EST, 4:00 PM CET

Nov 19, 2020 04:00 PM in Brussels

Webinar logo
Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: Team Novosanis.